{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T19:39:06Z","timestamp":1791920346238,"version":"4.3.4"},"reference-count":127,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2012,1,1]],"date-time":"2012-01-01T00:00:00Z","timestamp":1325376000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Diabetes and its Complications"],"published-print":{"date-parts":[[2012,1]]},"DOI":"10.1016\/j.jdiacomp.2011.11.004","type":"journal-article","created":{"date-parts":[[2012,1,6]],"date-time":"2012-01-06T10:38:25Z","timestamp":1325846305000},"page":"56-64","source":"Crossref","is-referenced-by-count":146,"title":["Recent advances in understanding the biochemical and molecular mechanism of diabetic retinopathy"],"prefix":"10.1016","volume":"26","author":[{"given":"Mohammad Shamsul","family":"Ola","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohd Imtiaz","family":"Nawaz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. Mairaj","family":"Siddiquei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saleh","family":"Al-Amro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmed M.","family":"Abu El-Asrar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jdiacomp.2011.11.004_bb0005","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1586\/eop.09.52","article-title":"Pathophysiology and management of diabetic retinopathy","volume":"4","author":"Abu El-Asrar","year":"2009","journal-title":"Expert Review of Ophthalmology"},{"key":"10.1016\/j.jdiacomp.2011.11.004_bb0010","doi-asserted-by":"crossref","first-page":"2760","DOI":"10.1167\/iovs.03-1392","article-title":"Expression of apoptosis markers in the retinas of human subjects with diabetes","volume":"45","author":"Abu El-Asrar","year":"2004","journal-title":"Investigative Ophthalmology & Visual Science"},{"key":"10.1016\/j.jdiacomp.2011.11.004_bb0015","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/j.cyto.2009.11.004","article-title":"Roles of endothelin-1 and selected proinflammatory cytokines in the pathogenesis of proliferative diabetic retinopathy: analysis of vitreous samples","volume":"49","author":"Adamiec-Mroczek","year":"2010","journal-title":"Cytokine"},{"key":"10.1016\/j.jdiacomp.2011.11.004_bb0020","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1007\/s00281-008-0111-x","article-title":"Immunological mechanisms in the pathogenesis of diabetic retinopathy","volume":"30","author":"Adamis","year":"2008","journal-title":"Seminars in Immunopathology"},{"key":"10.1016\/j.jdiacomp.2011.11.004_bb0025","doi-asserted-by":"crossref","first-page":"403","DOI":"10.2217\/17460875.2.4.403","article-title":"Role of lipids in brain injury and diseases","volume":"2","author":"Adibhatla","year":"2007","journal-title":"Future Lipidology"},{"key":"10.1016\/j.jdiacomp.2011.11.004_bb0030","doi-asserted-by":"crossref","first-page":"2221","DOI":"10.1016\/j.ophtha.2006.07.032","article-title":"Effect of ruboxistaurin on visual loss in patients with diabetic retinopathy","volume":"113","author":"Aiello","year":"2006","journal-title":"Ophthalmology"},{"key":"10.1016\/j.jdiacomp.2011.11.004_bb0035","doi-asserted-by":"crossref","first-page":"614","DOI":"10.2337\/db10-0008","article-title":"Increased expression and activity of 12-lipoxygenase in oxygen-induced ischemic retinopathy and proliferative diabetic retinopathy: implications in retinal neovascularization","volume":"60","author":"Al-Shabrawey","year":"2011","journal-title":"Diabetes"},{"key":"10.1016\/j.jdiacomp.2011.11.004_bb0040","doi-asserted-by":"crossref","first-page":"3239","DOI":"10.1167\/iovs.08-1755","article-title":"Role of NADPH oxidase in retinal vascular inflammation","volume":"49","author":"Al-Shabrawey","year":"2008","journal-title":"Investigative Ophthalmology & Visual Science"},{"key":"10.1016\/j.jdiacomp.2011.11.004_bb0045","doi-asserted-by":"crossref","first-page":"537","DOI":"10.2174\/138161209787315701","article-title":"Fibrates and microvascular complications in diabetes\u2014insight from the FIELD study","volume":"15","author":"Ansquer","year":"2009","journal-title":"Current Pharmaceutical Design"},{"key":"10.1016\/j.jdiacomp.2011.11.004_bb0050","doi-asserted-by":"crossref","first-page":"2401","DOI":"10.2337\/db05-1635","article-title":"JDRF Diabetic Retinopathy Center Group. Diabetic retinopathy: seeing beyond glucose-induced microvascular disease","volume":"55","author":"Antonetti","year":"2006","journal-title":"Diabetes"},{"key":"10.1016\/j.jdiacomp.2011.11.004_bb0055","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.brainres.2006.10.031","article-title":"CNTF+BDNF treatment and neuroprotective pathways in the rd1 mouse retina","volume":"1129","author":"Azadi","year":"2007","journal-title":"Brain Research"},{"key":"10.1016\/j.jdiacomp.2011.11.004_bb0060","doi-asserted-by":"crossref","first-page":"4416","DOI":"10.1167\/iovs.10-5348","article-title":"Metabolic fingerprints of proliferative diabetic retinopathy: an 1H-NMR-based metabonomic approach using vitreous humor","volume":"51","author":"Barba","year":"2010","journal-title":"Investigative Ophthalmology & Visual Science"},{"key":"10.1016\/j.jdiacomp.2011.11.004_bb0065","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/S0278-5846(03)00023-X","article-title":"A new view of diabetic retinopathy: a neurodegenerative disease of the eye","volume":"27","author":"Barber","year":"2003","journal-title":"Progress in Neuro-Psychopharmacology & Biological Psychiatry"},{"key":"10.1016\/j.jdiacomp.2011.11.004_bb0070","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1172\/JCI2425","article-title":"Neural apoptosis in the retina during experimental and human diabetes. Early onset and effect of insulin","volume":"102","author":"Barber","year":"1998","journal-title":"The Journal of Clinical Investigation"},{"key":"10.1016\/j.jdiacomp.2011.11.004_bb0075","doi-asserted-by":"crossref","first-page":"2705","DOI":"10.1002\/jnr.21722","article-title":"Hypoxia-induced deactivation of NGF-mediated ERK1\/2 signaling in hippocampal cells: neuroprotection by acetyl-l-carnitine","volume":"86","author":"Barhwal","year":"2008","journal-title":"Journal of Neuroscience Research"},{"key":"10.1016\/j.jdiacomp.2011.11.004_bb0080","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1016\/S0140-6736(85)92250-0","article-title":"Severe retinopathy and mild carbohydrate intolerance: possible role of insulin deficiency and elevated circulating growth hormone","volume":"1","author":"Barnes","year":"1985","journal-title":"Lancet"},{"key":"10.1016\/j.jdiacomp.2011.11.004_bb0085","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1111\/j.1475-1313.2008.00595.x","article-title":"Nutritional supplementation for type 2 diabetes: a systematic review","volume":"28","author":"Bartlett","year":"2008","journal-title":"Ophthalmic & Physiological Optics"},{"key":"10.1016\/j.jdiacomp.2011.11.004_bb0090","doi-asserted-by":"crossref","first-page":"3259","DOI":"10.1167\/iovs.04-0308","article-title":"Local multifocal oscillatory potential abnormalities in diabetes and early diabetic retinopathy","volume":"45","author":"Bearse","year":"2004","journal-title":"Investigative Ophthalmology & Visual Science"},{"key":"10.1016\/j.jdiacomp.2011.11.004_bb0095","doi-asserted-by":"crossref","first-page":"804","DOI":"10.2337\/dc09-1679","article-title":"Inflammation and the incidence of type 2 diabetes: the Multi-Ethnic Study of Atherosclerosis (MESA)","volume":"33","author":"Bertoni","year":"2010","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jdiacomp.2011.11.004_bb0100","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1172\/JCI22869","article-title":"SDF-1 is both necessary and sufficient to promote proliferative retinopathy","volume":"115","author":"Butler","year":"2005","journal-title":"The Journal of Clinical Investigation"},{"key":"10.1016\/j.jdiacomp.2011.11.004_bb0105","first-page":"73","article-title":"Plasma levels of adrenomedullin, a vasoactive peptide, in type 2 diabetic patients with and without retinopathy","volume":"32","author":"Caliumi","year":"2007","journal-title":"Minerva Endocrinologica"},{"key":"10.1016\/j.jdiacomp.2011.11.004_bb0110","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1038\/nrn1078","article-title":"Neurotrophins and their receptors: a convergence point for many signalling pathways","volume":"4","author":"Chao","year":"2003","journal-title":"Nature Reviews. Neuroscience"},{"key":"10.1016\/j.jdiacomp.2011.11.004_bb0115","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.brainres.2009.04.054","article-title":"Taurine protects transformed rat retinal ganglion cells from hypoxia-induced apoptosis by preventing mitochondrial dysfunction","volume":"1279","author":"Chen","year":"2009","journal-title":"Brain Research"},{"key":"10.1016\/j.jdiacomp.2011.11.004_bb0120","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1001\/archopht.1996.01100140281004","article-title":"Association of elevated serum lipid levels with retinal hard exudate in diabetic retinopathy. Early Treatment Diabetic Retinopathy Study (ETDRS) Report 22","volume":"114","author":"Chew","year":"1996","journal-title":"Archives of Ophthalmology"},{"key":"10.1016\/j.jdiacomp.2011.11.004_bb0125","doi-asserted-by":"crossref","first-page":"3","DOI":"10.2174\/157339907779802139","article-title":"Leukocytes in diabetic retinopathy","volume":"3","author":"Chibber","year":"2007","journal-title":"Current Diabetes Reviews"},{"key":"10.1016\/j.jdiacomp.2011.11.004_bb0130","doi-asserted-by":"crossref","first-page":"475","DOI":"10.2174\/1389450054021891","article-title":"Aldose reductase in diabetic microvascular complications","volume":"6","author":"Chung","year":"2005","journal-title":"Current Drug Targets"},{"key":"10.1016\/j.jdiacomp.2011.11.004_bb0135","doi-asserted-by":"crossref","first-page":"3607","DOI":"10.1167\/iovs.08-2667","article-title":"Homocysteine levels in the vitreous of proliferative diabetic retinopathy and rhegmatogenous retinal detachment: its modulating role on lysyl oxidase","volume":"50","author":"Coral","year":"2009","journal-title":"Investigative Ophthalmology & Visual Science"},{"key":"10.1016\/j.jdiacomp.2011.11.004_bb0140","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1007\/s11064-005-6960-y","article-title":"The role of neurotrophins in brain aging: a perspective in honor of Regino Perez-Polo","volume":"30","author":"Cotman","year":"2005","journal-title":"Neurochemical Research"},{"key":"10.1016\/j.jdiacomp.2011.11.004_bb0145","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1002\/dmrr.431","article-title":"The role of lipids and protein kinase Cs in the pathogenesis of diabetic retinopathy","volume":"20","author":"Curtis","year":"2004","journal-title":"Diabetes\/Metabolism Research and Reviews"},{"key":"10.1016\/j.jdiacomp.2011.11.004_bb0150","doi-asserted-by":"crossref","first-page":"2404","DOI":"10.2337\/diabetes.53.9.2404","article-title":"Studies of rat and human retinas predict a role for the polyol pathway in human diabetic retinopathy","volume":"53","author":"Dagher","year":"2004","journal-title":"Diabetes"},{"key":"10.1016\/j.jdiacomp.2011.11.004_bb0155","doi-asserted-by":"crossref","first-page":"2913","DOI":"10.1517\/14656560903401620","article-title":"Ruboxistaurin: PKC-beta inhibition for complications of diabetes","volume":"10","author":"Danis","year":"2009","journal-title":"Expert Opinion on Pharmacotherapy"},{"key":"10.1016\/j.jdiacomp.2011.11.004_bb0160","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1016\/j.phrs.2007.04.016","article-title":"The role of protein kinase C activation and the vascular complications of diabetes","volume":"55","author":"Das Evcimen","year":"2007","journal-title":"Pharmacological Research"},{"key":"10.1016\/j.jdiacomp.2011.11.004_bb0165","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1167\/iovs.08-2473","article-title":"Effect of ruboxistaurin on the visual acuity decline associated with long-standing diabetic macular edema","volume":"50","author":"Davis","year":"2009","journal-title":"Investigative Ophthalmology & Visual Science"},{"key":"10.1016\/j.jdiacomp.2011.11.004_bb0170","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.exer.2005.10.031","article-title":"Increased glutamate levels in the vitreous of patients with retinal detachment","volume":"83","author":"Diederen","year":"2006","journal-title":"Experimental Eye Research"},{"key":"10.1016\/j.jdiacomp.2011.11.004_bb0175","doi-asserted-by":"crossref","first-page":"2726","DOI":"10.1167\/iovs.06-0076","article-title":"Reexamining the hyperglycemic pseudohypoxia hypothesis of diabetic oculopathy","volume":"47","author":"Diederen","year":"2006","journal-title":"Investigative Ophthalmology & Visual Science"},{"key":"10.1016\/j.jdiacomp.2011.11.004_bb0180","first-page":"667","article-title":"Aldose reductase inhibitor fidarestat counteracts diabetes-associated cataract formation, retinal oxidative\u2013nitrosative stress, glial activation, and apoptosis","volume":"21","author":"Drel","year":"2008","journal-title":"International Journal of Molecular Medicine"},{"key":"10.1016\/j.jdiacomp.2011.11.004_bb0185","doi-asserted-by":"crossref","first-page":"1778","DOI":"10.1167\/iovs.08-2191","article-title":"Poly(ADP-ribose)polymerase inhibition counteracts cataract formation and early retinal changes in streptozotocin-diabetic rats","volume":"50","author":"Drel","year":"2009","journal-title":"Investigative Ophthalmology & Visual Science"},{"key":"10.1016\/j.jdiacomp.2011.11.004_bb0190","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1172\/JCI200318127","article-title":"Inhibition of GAPDH activity by poly(ADP-ribose) polymerase activates three major pathways of hyperglycemic damage in endothelial cells","volume":"112","author":"Du","year":"2003","journal-title":"The Journal of Clinical Investigation"},{"key":"10.1016\/j.jdiacomp.2011.11.004_bb0195","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1097\/ICU.0b013e328330b533","article-title":"Changing paradigms in the treatment of diabetic retinopathy","volume":"20","author":"El-Asrar","year":"2009","journal-title":"Current Opinion in Ophthalmology"},{"key":"10.1016\/j.jdiacomp.2011.11.004_bb0200","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1159\/000083270","article-title":"Adrenomedullin and leptin levels in diabetic retinopathy and retinal diseases","volume":"219","author":"Er","year":"2005","journal-title":"Ophthalmologica"},{"key":"10.1016\/j.jdiacomp.2011.11.004_bb0205","doi-asserted-by":"crossref","first-page":"C927","DOI":"10.1152\/ajpcell.00140.2010","article-title":"Reactive oxygen species downregulate glucose transport system in retinal endothelial cells","volume":"300","author":"Fernandes","year":"2011","journal-title":"American Journal of Physiology. Cell Physiology"},{"key":"10.1016\/j.jdiacomp.2011.11.004_bb0210","doi-asserted-by":"crossref","first-page":"2699","DOI":"10.2174\/138161207781662920","article-title":"Neuronal and glial cell abnormality as predictors of progression of diabetic retinopathy","volume":"13","author":"Fletcher","year":"2007","journal-title":"Current Pharmaceutical Design"},{"key":"10.1016\/j.jdiacomp.2011.11.004_bb0215","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1007\/978-1-4419-6741-1_14","article-title":"Therapeutic strategies for diabetes and complications: a role for sphingolipids?","volume":"688","author":"Fox","year":"2010","journal-title":"Advances in Experimental Medicine and Biology"},{"key":"10.1016\/j.jdiacomp.2011.11.004_bb0220","first-page":"812","article-title":"Serum brain-derived neurotrophic factor in patients with type 2 diabetes mellitus: relationship to glucose metabolism and biomarkers of insulin resistance","volume":"41","author":"Fujinami","year":"2008","journal-title":"Investigative Ophthalmology & Visual Science"},{"key":"10.1016\/j.jdiacomp.2011.11.004_bb0225","doi-asserted-by":"crossref","first-page":"386","DOI":"10.2174\/138920111794480606","article-title":"Protein kinase C inhibitors in the treatment of diabetic retinopathy. Review","volume":"12","author":"G\u00e1lvez","year":"2011","journal-title":"Current Pharmaceutical Biotechnology"},{"key":"10.1016\/j.jdiacomp.2011.11.004_bb0230","doi-asserted-by":"crossref","first-page":"3","DOI":"10.4137\/OED.S2855","article-title":"Diabetes accelerates retinal neuronal cell death in a mouse model of endogenous hyperhomocysteinemia","volume":"1","author":"Ganapathy","year":"2009","journal-title":"Ophthalmology Eye Diseases"},{"key":"10.1016\/j.jdiacomp.2011.11.004_bb0235","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1161\/CIRCRESAHA.110.217117","article-title":"Activation of protein kinase C isoforms and its impact on diabetic complications","volume":"106","author":"Geraldes","year":"2010","journal-title":"Circulation Research"},{"key":"10.1016\/j.jdiacomp.2011.11.004_bb0240","doi-asserted-by":"crossref","first-page":"48","DOI":"10.5301\/EJO.2010.4447","article-title":"Pentosidine and N-carboxymethyl-lysine: biomarkers for type 2 diabetic retinopathy","volume":"21","author":"Ghanem","year":"2011","journal-title":"European Journal of Ophthalmology"},{"key":"10.1016\/j.jdiacomp.2011.11.004_bb0245","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1161\/CIRCRESAHA.110.223545","article-title":"Oxidative stress and diabetic complications","volume":"107","author":"Giacco","year":"2010","journal-title":"Circulation Research"},{"key":"10.1016\/j.jdiacomp.2011.11.004_bb0250","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1210\/jc.2007-1817","article-title":"Clinical review: the role of advanced glycation end products in progression and complications of diabetes","volume":"93","author":"Goh","year":"2008","journal-title":"The Journal of Clinical Endocrinology and Metabolism"},{"key":"10.1016\/j.jdiacomp.2011.11.004_bb0255","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1111\/j.1471-4159.2011.07206.x","article-title":"The influence of diabetes on glutamate metabolism in retinas","volume":"117","author":"Gowda","year":"2011","journal-title":"Journal of Neurochemistry"},{"key":"10.1016\/j.jdiacomp.2011.11.004_bb0260","doi-asserted-by":"crossref","first-page":"416","DOI":"10.2337\/diabetes.35.4.416","article-title":"Insulin like growth factors in vitreous. Studies in control and diabetic subjects with neovascularization","volume":"35","author":"Grant","year":"1986","journal-title":"Diabetes"},{"key":"10.1016\/j.jdiacomp.2011.11.004_bb0265","first-page":"2068","article-title":"Proliferation, migration, and ERK activation in human retinal endothelial cells through A(2B) adenosine receptor stimulation","volume":"42","author":"Grant","year":"2001","journal-title":"Investigative Ophthalmology & Visual Science"},{"key":"10.1016\/j.jdiacomp.2011.11.004_bb0270","doi-asserted-by":"crossref","first-page":"1809","DOI":"10.1001\/archopht.122.12.1809","article-title":"Multifocal electroretinogram and short-wavelength automated perimetry measures in diabetic eyes with little or no retinopathy","volume":"122","author":"Han","year":"2004","journal-title":"Archives of Ophthalmology"},{"key":"10.1016\/j.jdiacomp.2011.11.004_bb0275","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/S0306-4522(03)00599-2","article-title":"Potential role of glial cell line-derived neurotrophic factor receptors in M\u00fcller glial cells during light-induced retinal degeneration","volume":"122","author":"Harada","year":"2003","journal-title":"Neuroscience"},{"key":"10.1016\/j.jdiacomp.2011.11.004_bb0280","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1136\/bjo.60.6.459","article-title":"Diabetic retinopathy with normal glucose tolerance","volume":"60","author":"Harrower","year":"1976","journal-title":"The British Journal of Ophthalmology"},{"issue":"455","key":"10.1016\/j.jdiacomp.2011.11.004_bb0285","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.neulet.2009.03.073","article-title":"Growth hormone is present in the human retina and vitreous fluid","volume":"22","author":"Harvey","year":"2009","journal-title":"Neuroscience Letters"},{"key":"10.1016\/j.jdiacomp.2011.11.004_bb0290","doi-asserted-by":"crossref","first-page":"146","DOI":"10.3109\/02713680903447918","article-title":"Aldose reductase inhibitor fidarestat attenuates leukocyte-endothelial interactions in experimental diabetic rat retina in vivo","volume":"35","author":"Hattori","year":"2010","journal-title":"Current Eye Research"},{"key":"10.1016\/j.jdiacomp.2011.11.004_bb0295","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1096\/fj.01-0691fje","article-title":"Disruption of the taurine transporter gene (taut) leads to retinal degeneration in mice","volume":"16","author":"Heller-Stilb","year":"2002","journal-title":"FASEB Journal"},{"key":"10.1016\/j.jdiacomp.2011.11.004_bb0300","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1111\/j.1464-5491.2005.01538.x","article-title":"Interleukin-8, monocyte chemoattractant protein-1 and IL-10 in the vitreous fluid of patients with proliferative diabetic retinopathy","volume":"22","author":"Hern\u00e1ndez","year":"2005","journal-title":"Diabetic Medicine"},{"key":"10.1016\/j.jdiacomp.2011.11.004_bb0305","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1056\/NEJMoa0806470","article-title":"10-year follow-up of intensive glucose control in type 2 diabetes","volume":"359","author":"Holman","year":"2008","journal-title":"The New England Journal of Medicine"},{"key":"10.1016\/j.jdiacomp.2011.11.004_bb0310","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1182\/blood-2004-08-3178","article-title":"Monocyte chemoattractant protein-1-induced angiogenesis is mediated by vascular endothelial growth factor-A","volume":"105","author":"Hong","year":"2005","journal-title":"Blood"},{"issue":"52","key":"10.1016\/j.jdiacomp.2011.11.004_bb0315","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.1167\/iovs.10-5768","article-title":"TNF{alpha} is required for late BRB breakdown in diabetic retinopathy, and its inhibition prevents leukostasis and protects vessels and neurons from apoptosis","volume":"10","author":"Huang","year":"2011","journal-title":"Investigative Ophthalmology & Visual Science"},{"key":"10.1016\/j.jdiacomp.2011.11.004_bb0320","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.2337\/db10-1160","article-title":"Retinal microglial activation and inflammation induced by Amadori-glycated albumin in a rat model of diabetes","volume":"60","author":"Ibrahim","year":"2011","journal-title":"Diabetes"},{"issue":"2","key":"10.1016\/j.jdiacomp.2011.11.004_bb0325","doi-asserted-by":"crossref","first-page":"S115","DOI":"10.1007\/s001250051422","article-title":"Cytosolic NADH\/NAD, free radicals, and vascular dysfunction in early diabetes mellitus","volume":"40","author":"Ido","year":"1997","journal-title":"Diabetologia"},{"key":"10.1016\/j.jdiacomp.2011.11.004_bb0330","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/S0140-6736(10)60576-4","article-title":"ACCORD trial group. Effect of intensive treatment of hyperglycaemia on microvascular outcomes in type 2 diabetes: an analysis of the ACCORD randomised trial","volume":"376","author":"Ismail-Beigi","year":"2010","journal-title":"Lancet"},{"key":"10.1016\/j.jdiacomp.2011.11.004_bb0335","first-page":"130","article-title":"Proliferative diabetic retinopathy and relations among antioxidant activity, oxidative stress, and VEGF in the vitreous body","volume":"29","author":"Izuta","year":"2010","journal-title":"Molecular Vision"},{"key":"10.1016\/j.jdiacomp.2011.11.004_bb0340","doi-asserted-by":"crossref","first-page":"1450","DOI":"10.1096\/fj.03-1476fje","article-title":"A central role for inflammation in the pathogenesis of diabetic retinopathy","volume":"18","author":"Joussen","year":"2004","journal-title":"FASEB Journal"},{"key":"10.1016\/j.jdiacomp.2011.11.004_bb0345","unstructured":"Kang Derwent, J.J., & Mieler, W.F. (2008). Thermoresponsive hydrogels as a new ocular drug delivery platform to the posterior segment of the eye. Transactions of the American Ophthalmological Society, 106, 206-13, 213-214."},{"key":"10.1016\/j.jdiacomp.2011.11.004_bb0350","doi-asserted-by":"crossref","first-page":"227","DOI":"10.2337\/db08-1025","article-title":"Role of glyceraldehyde 3-phosphate dehydrogenase in the development and progression of diabetic retinopathy","volume":"58","author":"Kanwar","year":"2009","journal-title":"Diabetes"},{"issue":"586","key":"10.1016\/j.jdiacomp.2011.11.004_bb0355","doi-asserted-by":"crossref","first-page":"4401","DOI":"10.1113\/jphysiol.2008.156695","article-title":"Retinal ganglion cells in diabetes","volume":"15","author":"Kern","year":"2008","journal-title":"The Journal of Physiology"},{"key":"10.1016\/j.jdiacomp.2011.11.004_bb0360","doi-asserted-by":"crossref","first-page":"2550","DOI":"10.2353\/ajpath.2010.091062","article-title":"Overexpression of Bcl-2 in vascular endothelium inhibits the microvascular lesions of diabetic retinopathy","volume":"176","author":"Kern","year":"2010","journal-title":"The American Journal of Pathology"},{"key":"10.1016\/j.jdiacomp.2011.11.004_bb0365","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1093\/emboj\/19.6.1290","article-title":"BDNF regulates eating behavior and locomotor activity in mice","volume":"19","author":"Kernie","year":"2000","journal-title":"The EMBO Journal"},{"key":"10.1016\/j.jdiacomp.2011.11.004_bb0370","doi-asserted-by":"crossref","first-page":"43603","DOI":"10.1155\/2007\/43603","article-title":"Oxidative stress and diabetic retinopathy","volume":"2007","author":"Kowluru","year":"2007","journal-title":"Experimental Diabetes Research"},{"key":"10.1016\/j.jdiacomp.2011.11.004_bb0375","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/j.brainresbull.2009.05.006","article-title":"Metabolic memory in diabetes\u2014from in vitro oddity to in vivo problem: role of apoptosis","volume":"81","author":"Kowluru","year":"2010","journal-title":"Brain Research Bulletin"},{"key":"10.1016\/j.jdiacomp.2011.11.004_bb0380","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1016\/j.exer.2010.02.006","article-title":"Metabolic memory and diabetic retinopathy: role of inflammatory mediators in retinal pericytes","volume":"90","author":"Kowluru","year":"2010","journal-title":"Experimental Eye Research"},{"key":"10.1016\/j.jdiacomp.2011.11.004_bb0385","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1007\/s00125-006-0537-4","article-title":"Brain-derived neurotrophic factor (BDNF) and type 2 diabetes","volume":"50","author":"Krabbe","year":"2007","journal-title":"Diabetologia"},{"key":"10.1016\/j.jdiacomp.2011.11.004_bb0390","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1096\/fj.03-0473com","article-title":"Cyclooxygenase 2 is a key enzyme for inflammatory cytokine-induced angiogenesis","volume":"18","author":"Kuwano","year":"2004","journal-title":"FASEB Journal"},{"issue":"362","key":"10.1016\/j.jdiacomp.2011.11.004_bb0395","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1056\/NEJMoa0905633","article-title":"Use of the thyroid hormone analogue eprotirome in statin-treated dyslipidemia","volume":"11","author":"Ladenson","year":"2010","journal-title":"The New England Journal of Medicine"},{"key":"10.1016\/j.jdiacomp.2011.11.004_bb0400","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1046\/j.1442-9071.2000.00222.x","article-title":"Penn State Retina Research Group. Retinal neurodegeneration: early pathology in diabetes","volume":"28","author":"Lieth","year":"2000","journal-title":"Clinical & Experimental Ophthalmology"},{"key":"10.1016\/j.jdiacomp.2011.11.004_bb0405","doi-asserted-by":"crossref","first-page":"61038","DOI":"10.1155\/2007\/61038","article-title":"The polyol pathway as a mechanism for diabetic retinopathy: attractive, elusive, and resilient","volume":"2007","author":"Lorenzi","year":"2007","journal-title":"Experimental Diabetes Research"},{"key":"10.1016\/j.jdiacomp.2011.11.004_bb0410","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1007\/s11154-008-9090-4","article-title":"Oxidative stress and diabetic retinopathy: pathophysiological mechanisms and treatment perspectives","volume":"9","author":"Madsen-Bouterse","year":"2008","journal-title":"Reviews in Endocrine & Metabolic Disorders"},{"key":"10.1016\/j.jdiacomp.2011.11.004_bb0415","doi-asserted-by":"crossref","first-page":"3330","DOI":"10.1167\/iovs.04-0247","article-title":"Death of retinal neurons in streptozotocin-induced diabetic mice","volume":"45","author":"Martin","year":"2004","journal-title":"Investigative Ophthalmology & Visual Science"},{"key":"10.1016\/j.jdiacomp.2011.11.004_bb0420","doi-asserted-by":"crossref","first-page":"6541","DOI":"10.1016\/j.biomaterials.2009.08.025","article-title":"Subconjunctivally implantable hydrogels with degradable and thermoresponsive properties for sustained release of insulin to the retina","volume":"30","author":"Misra","year":"2009","journal-title":"Biomaterials"},{"key":"10.1016\/j.jdiacomp.2011.11.004_bb0425","doi-asserted-by":"crossref","first-page":"4342","DOI":"10.1167\/iovs.06-1473","article-title":"Suppression of diabetes-induced retinal inflammation by blocking the angiotensin II type 1 receptor or its downstream nuclear factor-kappaB pathway","volume":"48","author":"Nagai","year":"2007","journal-title":"Investigative Ophthalmology & Visual Science"},{"key":"10.1016\/j.jdiacomp.2011.11.004_bb0430","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.plipres.2007.12.002","article-title":"Bioactive lipids in metabolic syndrome","volume":"47","author":"Nagao","year":"2008","journal-title":"Progress in Lipid Research"},{"key":"10.1016\/j.jdiacomp.2011.11.004_bb0435","doi-asserted-by":"crossref","first-page":"43748","DOI":"10.1074\/jbc.M108594200","article-title":"Excessive hexosamines block the neuroprotective effect of insulin and induce apoptosis in retinal neurons","volume":"276","author":"Nakamura","year":"2001","journal-title":"The Journal of Biological Chemistry"},{"key":"10.1016\/j.jdiacomp.2011.11.004_bb0440","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.ophtha.2008.09.034","article-title":"Vitreous levels of interleukin-6 and vascular endothelial growth factor in macular edema with central retinal vein occlusion","volume":"116","author":"Noma","year":"2009","journal-title":"Ophthalmology"},{"key":"10.1016\/j.jdiacomp.2011.11.004_bb0445","doi-asserted-by":"crossref","first-page":"2931","DOI":"10.2337\/diabetes.53.11.2931","article-title":"Interactions between hyperglycemia and hypoxia: implications for diabetic retinopathy","volume":"53","author":"Nyengaard","year":"2004","journal-title":"Diabetes"},{"key":"10.1016\/j.jdiacomp.2011.11.004_bb0450","doi-asserted-by":"crossref","first-page":"373","DOI":"10.2174\/138920111794480642","article-title":"Aldose reductase\/polyol inhibitors for diabetic retinopathy","volume":"12","author":"Obrosova","year":"2011","journal-title":"Current Pharmaceutical Biotechnology"},{"key":"10.1016\/j.jdiacomp.2011.11.004_bb0455","doi-asserted-by":"crossref","first-page":"234","DOI":"10.2337\/diabetes.54.1.234","article-title":"Aldose reductase inhibition counteracts oxidative\u2013nitrosative stress and poly(ADP-ribose) polymerase activation in tissue sites for diabetes complications","volume":"54","author":"Obrosova","year":"2005","journal-title":"Diabetes"},{"key":"10.1016\/j.jdiacomp.2011.11.004_bb0460","doi-asserted-by":"crossref","first-page":"E1057","DOI":"10.1152\/ajpendo.00323.2005","article-title":"Analysis of glucose metabolism in diabetic rat retinas","volume":"290","author":"Ola","year":"2006","journal-title":"American Journal of Physiology. Endocrinology and Metabolism"},{"key":"10.1016\/j.jdiacomp.2011.11.004_bb0465","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1016\/j.neuint.2011.06.010","article-title":"Regulation of glutamate metabolism by hydrocortisone and branched chain keto acids in cultured rat retinal M\u00fcller cells (TR-MUL)","volume":"59","author":"Ola","year":"2011","journal-title":"Neurochemistry International"},{"key":"10.1016\/j.jdiacomp.2011.11.004_bb0470","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1006\/bbrc.1997.7220","article-title":"Brain-derived neurotrophic factor reduces blood glucose level in obese diabetic mice but not in normal mice","volume":"238","author":"Ono","year":"1997","journal-title":"Biochemical and Biophysical Research Communications"},{"key":"10.1016\/j.jdiacomp.2011.11.004_bb0475","doi-asserted-by":"crossref","first-page":"867","DOI":"10.2337\/diabetes.50.4.867","article-title":"Angiotensin II induces expression of the Tie2 receptor ligand, angiopoietin-2, in bovine retinal endothelial cells","volume":"50","author":"Otani","year":"2001","journal-title":"Diabetes"},{"key":"10.1016\/j.jdiacomp.2011.11.004_bb0480","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1016\/j.ajo.2007.11.011","article-title":"Serum and tear levels of nerve growth factor in diabetic retinopathy patients","volume":"145","author":"Park","year":"2008","journal-title":"American Journal of Ophthalmology"},{"key":"10.1016\/j.jdiacomp.2011.11.004_bb0485","doi-asserted-by":"crossref","first-page":"2560","DOI":"10.1056\/NEJMoa0802987","article-title":"Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes","volume":"358","author":"Patel","year":"2008","journal-title":"The New England Journal of Medicine"},{"key":"10.1016\/j.jdiacomp.2011.11.004_bb0490","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1016\/j.mad.2010.03.005","article-title":"The role of vitamin E and oxidative stress in diabetes complications","volume":"131","author":"Pazdro","year":"2010","journal-title":"Mechanisms of Ageing and Development"},{"key":"10.1016\/j.jdiacomp.2011.11.004_bb0495","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/S0002-9440(10)63311-1","article-title":"Insulin-like growth factor-I plays a pathogenetic role in diabetic retinopathy","volume":"165","author":"Poulaki","year":"2004","journal-title":"The American Journal of Pathology"},{"key":"10.1016\/j.jdiacomp.2011.11.004_bb0500","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.2337\/diabetes.55.04.06.db05-0744","article-title":"Diabetes reduces basal retinal insulin receptor signaling: reversal with systemic and local insulin","volume":"55","author":"Reiter","year":"2006","journal-title":"Diabetes"},{"key":"10.1016\/j.jdiacomp.2011.11.004_bb0505","doi-asserted-by":"crossref","first-page":"3","DOI":"10.2174\/157339909787314176","article-title":"Metabolic control and diabetic retinopathy","volume":"5","author":"Rodriguez-Fontal","year":"2009","journal-title":"Current Diabetes Reviews"},{"key":"10.1016\/j.jdiacomp.2011.11.004_bb0510","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.1161\/01.CIR.0000089129.51288.BA","article-title":"Connective tissue growth factor is a mediator of angiotensin II-induced fibrosis","volume":"108","author":"Ruperez","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.jdiacomp.2011.11.004_bb0515","first-page":"443","article-title":"A retinal cell damage due to oxidative stress in diabetic retinopathy","volume":"46","author":"Sato","year":"2005","journal-title":"Investigative Ophthalmology & Visual Science"},{"key":"10.1016\/j.jdiacomp.2011.11.004_bb0520","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.2337\/db08-0254","article-title":"(Pro)renin receptor-mediated signal transduction and tissue renin-angiotensin system contribute to diabetes-induced retinal inflammation","volume":"58","author":"Satofuka","year":"2009","journal-title":"Diabetes"},{"key":"10.1016\/j.jdiacomp.2011.11.004_bb0525","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1358\/dot.2009.045.004.1354195","article-title":"Ruboxistaurin mesilate hydrate for diabetic retinopathy","volume":"45","author":"Schwartz","year":"2009","journal-title":"Drugs Today (Barc)"},{"key":"10.1016\/j.jdiacomp.2011.11.004_bb0530","doi-asserted-by":"crossref","first-page":"2412","DOI":"10.2337\/diabetes.53.9.2412","article-title":"Involvement of brain-derived neurotrophic factor in early retinal neuropathy of streptozotocin-induced diabetes in rats: therapeutic potential of brain-derived neurotrophic factor for dopaminergic amacrine cells","volume":"53","author":"Seki","year":"2004","journal-title":"Diabetes"},{"key":"10.1016\/j.jdiacomp.2011.11.004_bb0535","doi-asserted-by":"crossref","first-page":"1706","DOI":"10.1126\/science.276.5319.1706","article-title":"Essential role of growth hormone in ischemia-induced retinal neovascularization","volume":"276","author":"Smith","year":"1997","journal-title":"Science"},{"key":"10.1016\/j.jdiacomp.2011.11.004_bb0540","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1136\/bjo.85.6.746","article-title":"Advanced glycation: an important pathological event in diabetic and age related ocular disease","volume":"85","author":"Stitt","year":"2001","journal-title":"The British Journal of Ophthalmology"},{"key":"10.1016\/j.jdiacomp.2011.11.004_bb0545","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1006\/mcbr.2000.0243","article-title":"Advanced glycation end products induce blood\u2013retinal barrier dysfunction in normoglycemic rats","volume":"3","author":"Stitt","year":"2000","journal-title":"Molecular and Cellular Biology Research Communications"},{"key":"10.1016\/j.jdiacomp.2011.11.004_bb0560","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.mvr.2010.03.004","article-title":"Hyperglycemia attenuates acute permeability response to advanced glycation end products in retinal microvasculature","volume":"80","author":"Warboys","year":"2010","journal-title":"Microvascular Research"},{"key":"10.1016\/j.jdiacomp.2011.11.004_bb0565","first-page":"300","article-title":"Alteration of growth factors and neuronal death in diabetic retinopathy: what we have learned so far","volume":"17","author":"Whitmire","year":"2011","journal-title":"Molecular Vision"},{"key":"10.1016\/j.jdiacomp.2011.11.004_bb0570","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.2337\/diacare.27.5.1047","article-title":"Global prevalence of diabetes: estimates for the year 2000 and projections for 2030","volume":"27","author":"Wild","year":"2004","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jdiacomp.2011.11.004_bb0575","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1100\/tsw.2008.25","article-title":"Update on the treatment of diabetic retinopathy","volume":"8","author":"Wilkinson-Berka","year":"2008","journal-title":"Scientific World Journal"},{"key":"10.1016\/j.jdiacomp.2011.11.004_bb0580","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1161\/CIRCRESAHA.108.176008","article-title":"Identification of a retinal aldosterone system and the protective effects of mineralocorticoid receptor antagonism on retinal vascular pathology","volume":"104","author":"Wilkinson-Berka","year":"2009","journal-title":"Circulation Research"},{"key":"10.1016\/j.jdiacomp.2011.11.004_bb0585","doi-asserted-by":"crossref","first-page":"3307","DOI":"10.2174\/092986706778773086","article-title":"The role of growth hormone, insulin-like growth factor and somatostatin in diabetic retinopathy","volume":"13","author":"Wilkinson-Berka","year":"2006","journal-title":"Current Medicinal Chemistry"},{"key":"10.1016\/j.jdiacomp.2011.11.004_bb0590","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1111\/j.1744-9987.2009.00775.x","article-title":"Advanced glycation end products and receptor-oxidative stress system in diabetic vascular complications","volume":"13","author":"Yamagishi","year":"2009","journal-title":"Therapeutic Apheresis and Dialysis"},{"key":"10.1016\/j.jdiacomp.2011.11.004_bb0595","doi-asserted-by":"crossref","first-page":"362","DOI":"10.2174\/138920111794480534","article-title":"Advanced glycation end products (AGEs), oxidative stress and diabetic retinopathy","volume":"12","author":"Yamagishi","year":"2011","journal-title":"Current Pharmaceutical Biotechnology"},{"key":"10.1016\/j.jdiacomp.2011.11.004_bb0600","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1159\/000111152","article-title":"Olmesartan blocks inflammatory reactions in endothelial cells evoked by advanced glycation end products by suppressing generation of reactive oxygen species","volume":"40","author":"Yamagishi","year":"2007","journal-title":"Ophthalmic Research"},{"key":"10.1016\/j.jdiacomp.2011.11.004_bb0605","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.2174\/138945008786786154","article-title":"Pigment epithelium derived factor (PEDF): its potential therapeutic implication in diabetic vascular complications","volume":"9","author":"Yamagishi","year":"2008","journal-title":"Current Drug Targets"},{"key":"10.1016\/j.jdiacomp.2011.11.004_bb0610","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1159\/000099244","article-title":"Pigment-epithelium-derived factor suppresses expression of receptor for advanced glycation end products in the eye of diabetic rats","volume":"39","author":"Yamagishi","year":"2007","journal-title":"Ophthalmic Research"},{"key":"10.1016\/j.jdiacomp.2011.11.004_bb0615","doi-asserted-by":"crossref","first-page":"2946","DOI":"10.2337\/db07-0291","article-title":"Stromal cell derived factor-1 (SDF-1)\/CXCL12 attenuates diabetes in mice and promotes pancreatic beta-cell survival by activation of the prosurvival kinase Akt","volume":"56","author":"Yano","year":"2007","journal-title":"Diabetes"},{"key":"10.1016\/j.jdiacomp.2011.11.004_bb0620","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1016\/j.exer.2009.08.006","article-title":"Time-dependent reduction of glutamine synthetase in retina of diabetic rats","volume":"89","author":"Yu","year":"2009","journal-title":"Experimental Eye Research"},{"key":"10.1016\/j.jdiacomp.2011.11.004_bb0625","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1161\/01.HYP.0000113628.94574.0f","article-title":"Retinal expression of vascular endothelial growth factor Is mediated by angiotensin type 1 and type 2 receptors","volume":"43","author":"Zhang","year":"2004","journal-title":"Hypertension"},{"key":"10.1016\/j.jdiacomp.2011.11.004_bb0630","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1186\/1471-2202-7-49","article-title":"Glutamate-induced apoptosis in neuronal cells is mediated via caspase-dependent and independent mechanisms involving calpain and caspase-3 proteases as well as apoptosis inducing factor (AIF) and this process is inhibited by equine estrogens","volume":"7","author":"Zhang","year":"2006","journal-title":"BMC Neuroscience"},{"key":"10.1016\/j.jdiacomp.2011.11.004_bb0635","doi-asserted-by":"crossref","first-page":"3974","DOI":"10.2741\/3505","article-title":"Role of nitric oxide, superoxide, peroxynitrite and PARP in diabetic retinopathy","volume":"14","author":"Zheng","year":"2009","journal-title":"Frontiers in Bioscience"},{"key":"10.1016\/j.jdiacomp.2011.11.004_bb0640","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.2337\/db10-0133","article-title":"Epigenetic changes in mitochondrial superoxide dismutase in the retina and the development of diabetic retinopathy","volume":"60","author":"Zhong","year":"2011","journal-title":"Diabetes"},{"key":"10.1016\/j.jdiacomp.2011.11.004_bb0645","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1007\/s11892-011-0198-7","article-title":"AGEs, RAGE, and diabetic retinopathy","volume":"11","author":"Zong","year":"2011","journal-title":"Current Diabetes Reports"}],"container-title":["Journal of Diabetes and its Complications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1056872711001541?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1056872711001541?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,6,22]],"date-time":"2019-06-22T04:42:23Z","timestamp":1561178543000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1056872711001541"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,1]]},"references-count":127,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2012,1]]}},"alternative-id":["S1056872711001541"],"URL":"https:\/\/doi.org\/10.1016\/j.jdiacomp.2011.11.004","relation":{},"ISSN":["1056-8727"],"issn-type":[{"value":"1056-8727","type":"print"}],"subject":[],"published":{"date-parts":[[2012,1]]}}}